Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting
Authors
Keywords
-
Journal
JACC-Cardiovascular Interventions
Volume 14, Issue 21, Pages 2330-2340
Publisher
Elsevier BV
Online
2021-11-02
DOI
10.1016/j.jcin.2021.07.045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
- (2020) Masato Nakamura et al. CIRCULATION JOURNAL
- Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI
- (2020) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results from a Nationwide Danish Cohort Study
- (2019) Nienke van Rein et al. CIRCULATION
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation
- (2019) So-Ryoung Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Philip Urban et al. CIRCULATION
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Incidence and Details of Bleeding Events After Everolimus-Eluting Stent Implantation ― 7–8-Year Outcomes ―
- (2019) Katsuya Miura et al. CIRCULATION JOURNAL
- From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient
- (2019) Armin Arbab-Zadeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
- (2019) Satoshi Yasuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study
- (2018) Satoshi Yasuda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
- (2014) Morten Lamberts et al. CIRCULATION
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation
- (2011) Takeshi Kimura et al. CIRCULATION
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now